Anbio Biotechnology Files 2025 Annual Report

Ticker: NNNN · Form: 20-F · Filed: 2026-04-07T16:15:24-04:00

Sentiment: neutral

Topics: annual-report, 20-F, foreign-issuer

TL;DR

Anbio Biotech dropped its 2025 20-F, check the financials for Frankfurt-based ops.

AI Summary

Anbio Biotechnology filed its annual report on Form 20-F on April 7, 2026, for the fiscal year ending December 31, 2025. The filing includes various exhibits such as financial statements and disclosures. The company's principal executive offices are located at Friedrich-Ebert-Anlage 49, Frankfurt am Main, Germany.

Why It Matters

This filing provides investors and analysts with the company's audited financial performance and disclosures for the 2025 fiscal year, crucial for evaluating its business and investment potential.

Risk Assessment

Risk Level: medium — As a foreign private issuer filing a 20-F, the company operates under different regulatory and reporting standards than domestic US companies, which can introduce complexity and risk.

Key Numbers

1169205 — FORM 20-F size (Size of the main 20-F filing document in bytes.)
4222023 — Complete submission text file size (Total size of the complete submission text file in bytes.)

Key Players & Entities

Anbio Biotechnology (company) — Filer of the 20-F report
0001982708 (company) — CIK number for Anbio Biotechnology
2026-04-07 (date) — Filing date of the 20-F
2025-12-31 (date) — Period of report (fiscal year end)
Friedrich-Ebert-Anlage 49, Frankfurt am Main, Germany (location) — Mailing and business address of the company

FAQ

What is the primary purpose of the Form 20-F filing?

The Form 20-F is an annual report required for foreign private issuers with securities registered in the United States, providing comprehensive financial and operational information for the fiscal year.

When did Anbio Biotechnology file its 2025 annual report?

Anbio Biotechnology filed its 20-F report on April 7, 2026.

What is the fiscal year end for Anbio Biotechnology as indicated in the filing?

The fiscal year end for Anbio Biotechnology is December 31, 2025.

Where are Anbio Biotechnology's principal executive offices located?

Anbio Biotechnology's principal executive offices are located at Friedrich-Ebert-Anlage 49, Frankfurt am Main, Germany.

What is the SIC code for Anbio Biotechnology and what industry does it represent?

The SIC code for Anbio Biotechnology is 2835, which represents 'In Vitro & In Vivo Diagnostic Substances'.

From the Filing

EDGAR Filing Documents for 0001185185-26-001294 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: SEC Accession No. 0001185185-26-001294 Filing Date 2026-04-07 Accepted 2026-04-07 16:15:24 Documents 61 Period of Report 2025-12-31 Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 20-F anbio20f123125.htm iXBRL 20-F 1169205 2 EXHIBIT 2.1 anbioex2-1.htm EX-2.1 66514 3 EXHIBIT 8.1 anbioex8-1.htm EX-8.1 5340 4 EXHIBIT 11.2 anbioex11-2.htm EX-11.2 38875 5 EXHIBIT 12.1 anbioex12-1.htm EX-12.1 9218 6 EXHIBIT 12.2 anbioex12-2.htm EX-12.2 9145 7 EXHIBIT 13.1 anbioex13-1.htm EX-13.1 3348 8 EXHIBIT 13.2 anbioex13-2.htm EX-13.2 3347 9 GRAPHIC image_001.jpg GRAPHIC 13223 10 GRAPHIC image_002.jpg GRAPHIC 30744 Complete submission text file 0001185185-26-001294.txt 4222023 Data Files Seq Description Document Type Size 11 XBRL SCHEMA FILE nnnn-20251231.xsd EX-101.SCH 27337 12 XBRL CALCULATION FILE nnnn-20251231_cal.xml EX-101.CAL 26137 13 XBRL DEFINITION FILE nnnn-20251231_def.xml EX-101.DEF 145315 14 XBRL LABEL FILE nnnn-20251231_lab.xml EX-101.LAB 227261 15 XBRL PRESENTATION FILE nnnn-20251231_pre.xml EX-101.PRE 148974 64 EXTRACTED XBRL INSTANCE DOCUMENT anbio20f123125_htm.xml XML 307424 Mailing Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308 Business Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308 4916096247281 Anbio Biotechnology (Filer) CIK : 0001982708 (see all company filings) EIN. : 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231 Type: 20-F | Act: 34 | File No.: 001-42526 | Film No.: 26845105 SIC : 2835 In Vitro & In Vivo Diagnostic Substances (CF Office: 03 Life Sciences)